Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Multifocal epithelial tumors and field cancerization: stroma as a primary determinant
G. Paolo Dotto
G. Paolo Dotto
Published April 1, 2014
Citation Information: J Clin Invest. 2014;124(4):1446-1453. https://doi.org/10.1172/JCI72589.
View: Text | PDF
Review Article has an altmetric score of 3

Multifocal epithelial tumors and field cancerization: stroma as a primary determinant

  • Text
  • PDF
Abstract

It is increasingly evident that cancer results from altered organ homeostasis rather than from deregulated control of single cells or groups of cells. This applies especially to epithelial cancer, the most common form of human solid tumors and a major cause of cancer lethality. In the vast majority of cases, in situ epithelial cancer lesions do not progress into malignancy, even if they harbor many of the genetic changes found in invasive and metastatic tumors. While changes in tumor stroma are frequently viewed as secondary to changes in the epithelium, recent evidence indicates that they can play a primary role in both cancer progression and initiation. These processes may explain the phenomenon of field cancerization, i.e., the occurrence of multifocal and recurrent epithelial tumors that are preceded by and associated with widespread changes of surrounding tissue or organ “fields.”

Authors

G. Paolo Dotto

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2009 Total
Citations: 2 7 10 9 9 10 13 5 5 11 9 1 91
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2015 (9)

Title and authors Publication Year
The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease
T Seeger-Nukpezah, DM Geynisman, AS Nikonova, T Benzing, EA Golemis
Nature Reviews Nephrology 2015
Nanocytological Field Carcinogenesis Detection to Mitigate Overdiagnosis of Prostate Cancer: A Proof of Concept Study
HK Roy, CB Brendler, H Subramanian, D Zhang, C Maneval, J Chandler, L Bowen, KL Kaul, BT Helfand, CH Wang, M Quinn, J Petkewicz, M Paterakos, V Backman, N Kyprianou
PloS one 2015
Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation
MG Procopio, C Laszlo, DA Labban, DE Kim, P Bordignon, SH Jo, S Goruppi, E Menietti, P Ostano, U Ala, P Provero, W Hoetzenecker, V Neel, WW Kilarski, MA Swartz, C Brisken, K Lefort, GP Dotto
Nature Cell Biology 2015
Harnessing novel modalities: field carcinogenesis detection for personalizing prostate cancer management
N Momi, V Backman, CB Brendler, HK Roy
Future Oncology 2015
The Fine LINE: Methylation Drawing the Cancer Landscape
IR Miousse, I Koturbash
BioMed Research International 2015
Metabolic rewiring in cancer-associated fibroblasts provides a niche for oncogenesis and metastatic dissemination
J Liu, J Mi, BP Zhou
Molecular & Cellular Oncology 2015
Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat’s in the fire
Jung H. Suh, Julie D. Saba
Translational cancer research 2015
Inflammation Fuels Tumor Progress and Metastasis
Liu J, Lin PC, Zhou BP
Current pharmaceutical design 2015
NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal
Yoon SO, Kim EK, Lee M, Jung WY, Lee H, Kang Y, Jang YJ, Hong SW, Choi SH, Yang WI
Oncotarget 2015

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
150 readers on Mendeley
See more details